Isoflurane characteristics

The inhalational anesthetics have distinctly different solubility (affinity) characteristics in blood as well as in other tissues. These solubility differences are usually expressed as coefficients and indicate the number of volumes of a particular agent distributed in one phase, as compared with another, when the partial pressure is at equilibrium (Table 25.3). For example, isoflurane has a blood-to-gas partition coefficient (often referred to as the Ostwald solubility coefficient) of approximately 1.4. Thus, when the partial pressure has reached equilibrium, blood will contain 1.4 times as much isoflurane as an equal volume of alveolar air. The volume of the various anesthetics required to saturate blood is similar to that needed to saturate other body tissues (Table 25.3) that is, the blood-tissue partition coefficient is usually not more than 4 (that of adipose tissue is higher). 

Isoflurane was discovered by Terrell in 1965. It is a halogenated methyl ethyl ether and is a structural isomer of enflurane (Figure 3.2). It became commercially available in the UK in 1982. Physical characteristics (Table 3.2)... 

Halothane was introduced into clinical practice in 1956. It was not the first fluorinated anaesthetic— fluoroxene (Fluoromar) holds that distinction—but it was the first to achieve widespread acceptability. Halothane is a fluorinated alkane 1-bromo, 1-chloro -2,2,2-trifluoroethane (Figure 3.2). It has a characteristic odour, similar to chloroform, and requires a stabiliser, thymol (0.01%), to prevent degradation by light. Halothane has a blood/gas partition coefficient of 2.4 able 3.2) but its lack of irritant qualities makes possible the use of relatively high inspired concentrations (2-4%). For that reason, inhalation induction is characteristically smooth and rapid. Compared to sevoflurane, and possibly isoflurane, recovery from halothane anaesthesia is delayed. 

The newer volatile anesthetics, desflurane and sevoflurane, have physicochemical characteristics (ie, low blood gas partition coefficients) that are favorable to a more rapid onset and shorter duration of anesthetic actions compared with isoflurane and halothane. However, both of these newer agents also have certain limitations. The low volatility of desflurane necessitates the use of a specialized heated vaporizer, and the pungency of the drug leads to a high incidence of coughing and sympathomimetic side effects that make it less than ideally suited for induction of anesthesia. 

In the case of the newest agent, sevoflurane, induction of anesthesia is achieved rapidly and smoothly, and recovery is more rapid than most other inhaled anesthetics including isoflurane. However, sevoflurane is chemically unstable when exposed to carbon dioxide absorbents, degrading to an olefinic compound (fluoromethyl-2,2-difluoro-l-[trifluoromethyl]vinyl ether, compound A) that is potentially nephrotoxic. In addition, sevoflurane is metabolized by the liver to release fluoride ions, raising concerns about possible renal damage similar to that caused by methoxyflurane. Sevoflurane comes close to having the characteristics of an ideal gas anesthetic, but a relatively insoluble compound that has greater chemical stability could be a useful alternative in the future. 

It is pertinent to observe here that a number of volatile anaesthetics viz., halothane, isoflurane, enflurane and the like essentially contain in each of them an asymmetric carbon atom i.e., a chiral centre) therefore, may invariably occur both as (+)-or (-)-enantiomers. It has been a common practice to make use of these volatile anaesthetics as their racemates commercially however, another school of thought devised a mean to establish and determine the anaesthetic characteristics of individual enantiomers. 

Bock M, Klippel K, Nitsche B, Bach A, Martin E, Motsch J. Rocuronium potency and recovery characteristics during steady-state desflurane, sevoflurane, isoflurane or propofol anaes-diesia. BrJ Anaesth (2000) 84, 43-7. 

---